vs
Side-by-side financial comparison of Dexcom (DXCM) and MNTN, Inc. (MNTN). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $73.7M, roughly 17.1× MNTN, Inc.). Dexcom runs the higher net margin — 21.2% vs 11.9%, a 9.3% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 14.2%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
MNTN Inc. is a U.S.-headquartered advertising technology firm specializing in performance-driven connected TV (CTV) advertising solutions. It serves e-commerce, retail, and consumer goods brands, helping clients accurately measure ad campaign ROI and reach targeted audiences across streaming TV platforms in North American and European markets.
DXCM vs MNTN — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $73.7M |
| Net Profit | $267.3M | $8.8M |
| Gross Margin | 62.9% | 2748.6% |
| Operating Margin | 25.6% | 31.5% |
| Net Margin | 21.2% | 11.9% |
| Revenue YoY | 21.6% | 14.2% |
| Net Profit YoY | 153.6% | 141.5% |
| EPS (diluted) | $0.67 | $0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $73.7M | ||
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.2B | $70.0M | ||
| Q2 25 | $1.2B | $68.5M | ||
| Q1 25 | $1.0B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $994.2M | — | ||
| Q2 24 | $1.0B | — |
| Q1 26 | $267.3M | $8.8M | ||
| Q4 25 | $267.3M | — | ||
| Q3 25 | $283.8M | $6.4M | ||
| Q2 25 | $179.8M | $-26.2M | ||
| Q1 25 | $105.4M | — | ||
| Q4 24 | $151.7M | — | ||
| Q3 24 | $134.6M | — | ||
| Q2 24 | $143.5M | — |
| Q1 26 | 62.9% | 2748.6% | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | 78.9% | ||
| Q2 25 | 59.5% | 76.8% | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | 31.5% | ||
| Q4 25 | 25.6% | — | ||
| Q3 25 | 20.1% | 10.8% | ||
| Q2 25 | 18.4% | 5.4% | ||
| Q1 25 | 12.9% | — | ||
| Q4 24 | 17.0% | — | ||
| Q3 24 | 15.3% | — | ||
| Q2 24 | 15.7% | — |
| Q1 26 | 21.2% | 11.9% | ||
| Q4 25 | 21.2% | — | ||
| Q3 25 | 23.5% | 9.2% | ||
| Q2 25 | 15.5% | -38.3% | ||
| Q1 25 | 10.2% | — | ||
| Q4 24 | 13.6% | — | ||
| Q3 24 | 13.5% | — | ||
| Q2 24 | 14.3% | — |
| Q1 26 | $0.67 | $0.11 | ||
| Q4 25 | $0.67 | — | ||
| Q3 25 | $0.70 | $0.08 | ||
| Q2 25 | $0.45 | $-0.65 | ||
| Q1 25 | $0.27 | — | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.34 | — | ||
| Q2 24 | $0.35 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $213.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $318.6M |
| Total Assets | $6.3B | $375.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | $213.9M | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | $179.2M | ||
| Q2 25 | $1.2B | $175.2M | ||
| Q1 25 | $904.9M | — | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | — | ||
| Q2 24 | $939.2M | — |
| Q1 26 | $2.7B | $318.6M | ||
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.7B | $266.7M | ||
| Q2 25 | $2.6B | $238.9M | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $2.4B | — |
| Q1 26 | $6.3B | $375.1M | ||
| Q4 25 | $6.3B | — | ||
| Q3 25 | $7.5B | $335.9M | ||
| Q2 25 | $7.3B | $337.0M | ||
| Q1 25 | $6.8B | — | ||
| Q4 24 | $6.5B | — | ||
| Q3 24 | $6.4B | — | ||
| Q2 24 | $6.8B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $7.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 0.81× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $7.1M | ||
| Q4 25 | $294.0M | — | ||
| Q3 25 | $659.9M | $9.3M | ||
| Q2 25 | $303.0M | $17.6M | ||
| Q1 25 | $183.8M | — | ||
| Q4 24 | $301.4M | — | ||
| Q3 24 | $199.5M | — | ||
| Q2 24 | $279.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | — | ||
| Q3 25 | $579.4M | — | ||
| Q2 25 | $208.9M | — | ||
| Q1 25 | $96.8M | — | ||
| Q4 24 | $176.8M | — | ||
| Q3 24 | $88.3M | — | ||
| Q2 24 | $213.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | — | ||
| Q3 25 | 47.9% | — | ||
| Q2 25 | 18.1% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 15.9% | — | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | 21.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | — | ||
| Q3 25 | 6.7% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 8.4% | — | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 6.6% | — |
| Q1 26 | — | 0.81× | ||
| Q4 25 | 1.10× | — | ||
| Q3 25 | 2.33× | 1.45× | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 1.74× | — | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | — | ||
| Q2 24 | 1.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
